Published in Crit Care on September 08, 2004
Association between endothelial dysfunction and acute brain dysfunction during critical illness. Anesthesiology (2013) 1.75
Brain lesions in septic shock: a magnetic resonance imaging study. Intensive Care Med (2007) 1.69
Inhibition of complement C5a prevents breakdown of the blood-brain barrier and pituitary dysfunction in experimental sepsis. Crit Care (2009) 1.20
Hypothalamic inflammation: a double-edged sword to nutritional diseases. Ann N Y Acad Sci (2011) 1.11
The circumventricular organs participate in the immunopathogenesis of experimental autoimmune encephalomyelitis. Cerebrospinal Fluid Res (2005) 1.03
Streptococcus pneumoniae Infection aggravates experimental autoimmune encephalomyelitis via Toll-like receptor 2. Infect Immun (2006) 0.91
Clinical review: agitation and delirium in the critically ill--significance and management. Crit Care (2007) 0.90
Multiscale model for the assessment of autonomic dysfunction in human endotoxemia. Physiol Genomics (2010) 0.89
Cerebral perfusion in sepsis. Crit Care (2010) 0.87
Brain autopsy findings in intensive care unit patients previously suffering from delirium: a pilot study. J Crit Care (2010) 0.86
A physiological model for autonomic heart rate regulation in human endotoxemia. Shock (2011) 0.86
Sepsis-associated encephalopathy. Transl Med UniSa (2012) 0.83
Endocrine dysfunction in sepsis: a beneficial or deleterious host response? Germs (2015) 0.81
Mechanisms of brain signaling during sepsis. Curr Neuropharmacol (2009) 0.81
Lipopolysaccharide (LPS) potentiates hydrogen peroxide toxicity in T98G astrocytoma cells by suppression of anti-oxidative and growth factor gene expression. BMC Genomics (2008) 0.78
Characterization of Brain-Heart Interactions in a Rodent Model of Sepsis. Mol Neurobiol (2016) 0.76
Biomarkers in septic encephalopathy: a systematic review of clinical studies. Rev Bras Ter Intensiva (2013) 0.75
Neuroanatomy of sepsis-associated encephalopathy. Crit Care (2017) 0.75
Cortisol is an associated-risk factor of brain dysfunction in patients with severe sepsis and septic shock. Biomed Res Int (2014) 0.75
Blood-Brain Barrier Deterioration and Hippocampal Gene Expression in Polymicrobial Sepsis: An Evaluation of Endothelial MyD88 and the Vagus Nerve. PLoS One (2016) 0.75
Physiology Considerations in Geriatric Patients. Anesthesiol Clin (2015) 0.75
Presentations of adult septic patients in the prehospital setting as recorded by emergency medical services: a mixed methods analysis. Scand J Trauma Resusc Emerg Med (2017) 0.75
Cerebral Blood Flow Autoregulation in Sepsis for the Intensivist: Why Its Monitoring May Be the Future of Individualized Care. J Intensive Care Med (2016) 0.75
Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock. JAMA (2002) 16.37
Nicotinic acetylcholine receptor alpha7 subunit is an essential regulator of inflammation. Nature (2002) 12.09
Vagus nerve stimulation attenuates the systemic inflammatory response to endotoxin. Nature (2000) 11.49
Inflammatory blockade restores adult hippocampal neurogenesis. Science (2003) 10.14
Localization of nitric oxide synthase indicating a neural role for nitric oxide. Nature (1990) 7.23
The concepts of stress and stress system disorders. Overview of physical and behavioral homeostasis. JAMA (1992) 6.96
The hypothalamic-pituitary-adrenal axis and immune-mediated inflammation. N Engl J Med (1995) 6.17
Apoptosis in the nervous system. Nature (2000) 5.82
Nitric oxide mediates glutamate neurotoxicity in primary cortical cultures. Proc Natl Acad Sci U S A (1991) 5.70
Activation of innate immunity in the CNS triggers neurodegeneration through a Toll-like receptor 4-dependent pathway. Proc Natl Acad Sci U S A (2003) 5.11
A 3-level prognostic classification in septic shock based on cortisol levels and cortisol response to corticotropin. JAMA (2000) 4.92
Glutamate, nitric oxide and cell-cell signalling in the nervous system. Trends Neurosci (1991) 4.66
Vasopressin deficiency contributes to the vasodilation of septic shock. Circulation (1997) 4.54
Association between mitochondrial dysfunction and severity and outcome of septic shock. Lancet (2002) 4.42
The toll-like receptor TLR4 is necessary for lipopolysaccharide-induced oligodendrocyte injury in the CNS. J Neurosci (2002) 3.55
Broad expression of Toll-like receptors in the human central nervous system. J Neuropathol Exp Neurol (2002) 3.53
The neurologic basis of fever. N Engl J Med (1994) 3.38
Production of prostaglandin E and an interleukin-1 like factor by cultured astrocytes and C6 glioma cells. J Immunol (1982) 3.24
Pneumococcal trafficking across the blood-brain barrier. Molecular analysis of a novel bidirectional pathway. J Clin Invest (1998) 3.17
Regulation of the hypothalamic-pituitary-adrenal axis by cytokines: actions and mechanisms of action. Physiol Rev (1999) 2.77
Neuroendocrine pharmacology of stress. Eur J Pharmacol (2003) 2.77
Regional difference in susceptibility to lipopolysaccharide-induced neurotoxicity in the rat brain: role of microglia. J Neurosci (2000) 2.75
Toll-like receptor 4: the missing link of the cerebral innate immune response triggered by circulating gram-negative bacterial cell wall components. FASEB J (2001) 2.41
Inflammatory neurodegeneration mediated by nitric oxide from activated glia-inhibiting neuronal respiration, causing glutamate release and excitotoxicity. J Neurosci (2001) 2.40
Circulating vasopressin levels in septic shock. Crit Care Med (2003) 2.22
Molecular insights on the cerebral innate immune system. Brain Behav Immun (2003) 2.19
Nitric oxide in the pathogenesis of vascular disease. J Pathol (2000) 2.10
Impact of encephalopathy on mortality in the sepsis syndrome. The Veterans Administration Systemic Sepsis Cooperative Study Group. Crit Care Med (1990) 2.04
Cultured astrocytes express toll-like receptors for bacterial products. Glia (2003) 2.01
Cardiac variability in critically ill adults: influence of sepsis. Crit Care Med (2001) 1.94
Depletion of neurohypophyseal content of vasopressin in septic shock. Crit Care Med (2002) 1.86
The role of the vagus nerve in cytokine-to-brain communication. Ann N Y Acad Sci (1998) 1.74
Role of vasopressin in the management of septic shock. Intensive Care Med (2004) 1.74
Vagal immune-to-brain communication: a visceral chemosensory pathway. Auton Neurosci (2000) 1.71
Impaired subcortical and cortical sensory evoked potential pathways in septic patients. Crit Care Med (2002) 1.63
Cerebral blood flow is reduced in patients with sepsis syndrome. Crit Care Med (1989) 1.58
The neuropathology of septic shock. Brain Pathol (2004) 1.53
The spectrum of septic encephalopathy. Definitions, etiologies, and mortalities. JAMA (1996) 1.53
Immunostimulatory CpG-DNA activates murine microglia. J Immunol (2002) 1.52
Inducible nitric oxide synthase pathway in the central nervous system and vasopressin release during experimental septic shock. Crit Care Med (2002) 1.48
Inducible nitric oxide synthase gene expression in the brain during systemic inflammation. Nat Med (1996) 1.46
Inappropriate sympathetic activation at onset of septic shock: a spectral analysis approach. Am J Respir Crit Care Med (1999) 1.46
Pathophysiology of septic encephalopathy: a review. Crit Care Med (2000) 1.46
Electron microscopy of the effect of gram-negative endotoxin on the blood-brain barrier. J Comp Neurol (1966) 1.44
Rat brain vascular distribution of interleukin-1 type-1 receptor immunoreactivity: relationship to patterns of inducible cyclooxygenase expression by peripheral inflammatory stimuli. J Comp Neurol (2004) 1.41
Circulating cell wall components derived from gram-negative, not gram-positive, bacteria cause a profound induction of the gene-encoding Toll-like receptor 2 in the CNS. J Neurochem (2001) 1.41
Effects of circulating tumor necrosis factor on the neuronal activity and expression of the genes encoding the tumor necrosis factor receptors (p55 and p75) in the rat brain: a view from the blood-brain barrier. Neuroscience (1999) 1.40
Cytokines, chemokines, and cytokine receptors in human microglia. J Neurosci Res (2002) 1.39
The electroencephalogram in sepsis-associated encephalopathy. J Clin Neurophysiol (1992) 1.39
Cytokine activation of the HPA axis. Ann N Y Acad Sci (2000) 1.38
Mechanisms of CNS response to systemic immune challenge: the febrile response. Trends Neurosci (1997) 1.36
Impaired pressor sensitivity to noradrenaline in septic shock patients with and without impaired adrenal function reserve. Br J Clin Pharmacol (1998) 1.34
Effect of LPS on the permeability of the blood-brain barrier to insulin. Brain Res (2001) 1.34
Paraventricular nucleus of the hypothalamus and elevated sympathetic activity in heart failure: the altered inhibitory mechanisms. Acta Physiol Scand (2003) 1.32
IL-12 production by central nervous system microglia is inhibited by astrocytes. J Immunol (1997) 1.31
Temporal and spatial relationships between lipopolysaccharide-induced expression of Fos, interleukin-1beta and inducible nitric oxide synthase in rat brain. Neuroscience (1999) 1.31
Lipopolysaccharide-induced increase in signalling in hippocampus is abrogated by IL-10--a role for IL-1 beta? J Neurochem (2004) 1.31
Induction of pro-inflammatory cytokine mRNAs in the brain after peripheral injection of subseptic doses of lipopolysaccharide in the rat. J Neuroimmunol (1999) 1.31
Interleukin (IL) 1beta, IL-1 receptor antagonist, IL-10, and IL-13 gene expression in the central nervous system and anterior pituitary during systemic inflammation: pathophysiological implications. Proc Natl Acad Sci U S A (1997) 1.30
Apoptosis of neurons in cardiovascular autonomic centres triggered by inducible nitric oxide synthase after death from septic shock. Lancet (2003) 1.28
Role of reactive oxygen species in LPS-induced production of prostaglandin E2 in microglia. J Neurochem (2004) 1.24
Vasopressin pressor hypersensitivity in vasodilatory septic shock. Crit Care Med (1997) 1.24
Neurologic complications of critical medical illnesses. Crit Care Med (1993) 1.22
Regional induction of tumor necrosis factor alpha expression in the mouse brain after systemic lipopolysaccharide administration. Proc Natl Acad Sci U S A (1994) 1.22
Endotoxin-induced activation of cerebral catecholamine and serotonin metabolism: comparison with interleukin-1. J Pharmacol Exp Ther (1992) 1.22
Expression and regulation of interleukin-10 and interleukin-10 receptor in rat astroglial and microglial cells. Eur J Neurosci (2002) 1.19
Brain endothelial cells express cyclooxygenase-2 during lipopolysaccharide-induced fever: light and electron microscopic immunocytochemical studies. J Neurosci (1998) 1.19
Prostaglandin E receptor subtypes in cultured rat microglia and their role in reducing lipopolysaccharide-induced interleukin-1beta production. J Neurochem (1999) 1.19
Faecal peritonitis causes oedema and neuronal injury in pig cerebral cortex. Clin Sci (Lond) (1999) 1.16
The bacterial endotoxin lipopolysaccharide has the ability to target the brain in upregulating its membrane CD14 receptor within specific cellular populations. Brain Pathol (1998) 1.16
Dysfunction of vasomotor reactivity in severe sepsis and septic shock. Intensive Care Med (2001) 1.16
Interleukin (IL)-10 inhibits IL-6 production in microglia by preventing activation of NF-kappaB. Brain Res Mol Brain Res (2000) 1.13
Heat shock protein 70 suppresses astroglial-inducible nitric-oxide synthase expression by decreasing NFkappaB activation. J Biol Chem (1996) 1.13
Production of the cytokines interleukin 1 and 6 by murine brain microvessel endothelium and smooth muscle pericytes. J Neuroimmunol (1993) 1.12
Cloning and expression of inducible nitric oxide synthase from rat astrocytes. J Neurosci Res (1994) 1.12
Effect of acute systemic inflammatory response and cytokines on the transcription of the genes encoding cyclooxygenase enzymes (COX-1 and COX-2) in the rat brain. J Neurochem (1998) 1.11
Brain endothelial cell production of a neuroprotective cytokine, interleukin-6, in response to noxious stimuli. Brain Res (1999) 1.10
Induction of inhibitory factor kappaBalpha mRNA in the central nervous system after peripheral lipopolysaccharide administration: an in situ hybridization histochemistry study in the rat. Proc Natl Acad Sci U S A (1997) 1.10
The encephalopathy associated with septic illness. Clin Invest Med (1990) 1.07
Impaired adrenocorticotropic hormone response to bacterial endotoxin in mice deficient in prostaglandin E receptor EP1 and EP3 subtypes. Proc Natl Acad Sci U S A (2003) 1.07
Cerebral endothelial cells release TNF-alpha after stimulation with cell walls of Streptococcus pneumoniae and regulate inducible nitric oxide synthase and ICAM-1 expression via autocrine loops. J Immunol (1999) 1.04
Interleukin-1 induces c-Fos immunoreactivity in primary afferent neurons of the vagus nerve. Brain Res (1998) 1.03
Multifocal necrotizing leukoencephalopathy in septic shock. Crit Care Med (2002) 0.99
Dual role of inflammatory stimuli in activation-induced cell death of mouse microglial cells. Initiation of two separate apoptotic pathways via induction of interferon regulatory factor-1 and caspase-11. J Biol Chem (2001) 0.99
Interleukin-1 beta stimulates both central and peripheral release of vasopressin and oxytocin in the rat. Eur J Neurosci (1995) 0.99
Expression of vascular cell adhesion molecule-1 (VCAM-1) by human brain microvessel endothelial cells in primary culture. Microvasc Res (1995) 0.98
The mechanism of action of cytokines to control the release of hypothalamic and pituitary hormones in infection. Ann N Y Acad Sci (2000) 0.98
Sepsis-induced vasoparalysis does not involve the cerebral vasculature: indirect evidence from autoregulation and carbon dioxide reactivity studies. Br J Anaesth (1996) 0.97
Induction of nitric oxide synthase and nitric oxide-mediated apoptosis in neuronal PC12 cells after stimulation with tumor necrosis factor-alpha/lipopolysaccharide. J Neurochem (1998) 0.97
Inhibition of nitric oxide synthase attenuates blood-brain barrier disruption during experimental meningitis. Brain Res (1996) 0.96
Expression of inducible nitric oxide synthase by neurones following exposure to endotoxin and cytokine. Br J Pharmacol (1994) 0.96
NO as an autocrine mediator in the apoptosis of activated microglial cells: correlation between activation and apoptosis of microglial cells. Brain Res (2001) 0.95
Autonomic modulation of heart rate variability during endotoxin shock in rabbits. Crit Care Med (1995) 0.95
Spectral analysis of heart rate variability in the ICU: a measure of autonomic function. J Surg Res (1996) 0.94
Blood-brain barrier derangement in sepsis: cause of septic encephalopathy? Am J Surg (1981) 0.93
Modulation of cardiovascular control mechanisms and their interaction. Physiol Rev (1996) 0.90
Effect of lipopolysaccharide on the permeability and reactivity of the cerebral microcirculation: role of inducible nitric oxide synthase. Brain Res (1998) 0.90
Cerebral circulation and metabolism in patients with septic encephalopathy. Am J Emerg Med (1991) 0.90
CD40 expressed by human brain endothelial cells regulates CD4+ T cell adhesion to endothelium. J Neuroimmunol (2003) 0.89
Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2012. Crit Care Med (2013) 39.56
Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock, 2012. Intensive Care Med (2013) 17.37
Hydrocortisone therapy for patients with septic shock. N Engl J Med (2008) 15.85
Acute skeletal muscle wasting in critical illness. JAMA (2013) 6.38
Recommendations for the diagnosis and management of corticosteroid insufficiency in critically ill adult patients: consensus statements from an international task force by the American College of Critical Care Medicine. Crit Care Med (2008) 5.30
A prospective randomised multi-centre controlled trial on tight glucose control by intensive insulin therapy in adult intensive care units: the Glucontrol study. Intensive Care Med (2009) 4.13
Fluid resuscitation in sepsis: a systematic review and network meta-analysis. Ann Intern Med (2014) 3.96
Corticosteroid treatment and intensive insulin therapy for septic shock in adults: a randomized controlled trial. JAMA (2010) 3.50
The effects of etomidate on adrenal responsiveness and mortality in patients with septic shock. Intensive Care Med (2009) 3.30
Clinical practice guideline on diagnosis and treatment of hyponatraemia. Eur J Endocrinol (2014) 3.06
Volume targeted versus pressure support non-invasive ventilation in patients with super obesity and chronic respiratory failure: a randomised controlled trial. Thorax (2012) 2.66
Early tracheotomy versus prolonged endotracheal intubation in unselected severely ill ICU patients. Intensive Care Med (2008) 2.57
Quadriceps strength predicts mortality in patients with moderate to severe chronic obstructive pulmonary disease. Thorax (2006) 2.55
Clinical and electrophysiological predictors of respiratory failure in Guillain-Barré syndrome: a prospective study. Lancet Neurol (2006) 2.50
Practice parameters for hemodynamic support of sepsis in adult patients: 2004 update. Crit Care Med (2004) 2.33
ICU physicians should abandon the use of etomidate! Intensive Care Med (2005) 2.32
Outcome of acute mesenteric ischemia in the intensive care unit: a retrospective, multicenter study of 780 cases. Intensive Care Med (2015) 2.25
Circulating vasopressin levels in septic shock. Crit Care Med (2003) 2.22
Surgical approaches for lung volume reduction in emphysema. Clin Med (2014) 2.14
Clinical practice guideline on diagnosis and treatment of hyponatraemia. Nephrol Dial Transplant (2014) 2.10
Health status assessment in routine clinical practice: the chronic obstructive pulmonary disease assessment test score in outpatients. Respiration (2012) 1.99
Inhaled drugs and global warming: time to shift to dry powder inhalers. BMJ (2013) 1.98
Decompression sickness in urban divers in France. Int Marit Health (2012) 1.98
Patient-controlled positive end-expiratory pressure with neuromuscular disease: effect on speech in patients with tracheostomy and mechanical ventilation support. Chest (2013) 1.97
Immunotherapy for Guillain-Barré syndrome: a systematic review. Brain (2007) 1.87
Validity of six activity monitors in chronic obstructive pulmonary disease: a comparison with indirect calorimetry. PLoS One (2012) 1.77
Adrenal function in sepsis: the retrospective Corticus cohort study. Crit Care Med (2007) 1.74
Sepsis-associated delirium. Intensive Care Med (2007) 1.72
Validity of activity monitors in health and chronic disease: a systematic review. Int J Behav Nutr Phys Act (2012) 1.70
Academic boycott of Israel. Academic boycott of Israel is the least we can do. BMJ (2003) 1.70
Brain lesions in septic shock: a magnetic resonance imaging study. Intensive Care Med (2007) 1.69
Diabetic status and the relation of the three domains of glycemic control to mortality in critically ill patients: an international multicenter cohort study. Crit Care (2013) 1.66
Compartmentalization of the inflammatory response in sepsis and SIRS. J Endotoxin Res (2006) 1.66
Bronchoscopic volume reduction with valve implants in patients with severe emphysema. Lancet (2003) 1.64
Cardiovascular response to dopamine and early prediction of outcome in septic shock: a prospective multiple-center study. Crit Care Med (2005) 1.63
A balanced view of balanced solutions. Crit Care (2010) 1.61
Guillain-Barré syndrome following primary cytomegalovirus infection: a prospective cohort study. Clin Infect Dis (2011) 1.60
Brainstem responses can predict death and delirium in sedated patients in intensive care unit. Crit Care Med (2011) 1.59
The COPD assessment test (CAT): response to pulmonary rehabilitation. A multicentre, prospective study. Thorax (2011) 1.54
Hydrocortisone effects on cardiovascular variability in septic shock: a spectral analysis approach. Crit Care Med (2008) 1.54
The neuropathology of septic shock. Brain Pathol (2004) 1.53
Osmoregulation of vasopressin secretion is altered in the postacute phase of septic shock. Crit Care Med (2010) 1.53
Validity of physical activity monitors during daily life in patients with COPD. Eur Respir J (2013) 1.53
Quadriceps wasting and physical inactivity in patients with COPD. Eur Respir J (2012) 1.52
Reducing mortality in sepsis: new directions. Crit Care (2002) 1.52
StO₂ guided early resuscitation in subjects with severe sepsis or septic shock: a pilot randomised trial. J Clin Monit Comput (2013) 1.51
Small fibre impairment predicts neuropathic pain in Guillain-Barré syndrome. Pain (2010) 1.49
COPD in England: a comparison of expected, model-based prevalence and observed prevalence from general practice data. J Public Health (Oxf) (2010) 1.49
Finding the missing millions - the impact of a locally enhanced service for COPD on current and projected rates of diagnosis: a population-based prevalence study using interrupted time series analysis. Prim Care Respir J (2013) 1.49
The highs and lows of intensive insulin therapy. Am J Respir Crit Care Med (2006) 1.47
An Exploratory Study of Long-Term Outcome Measures in Critical Illness Survivors: Construct Validity of Physical Activity, Frailty, and Health-Related Quality of Life Measures. Crit Care Med (2016) 1.45
Treatment of osteoradionecrosis of the jaw: the case against the use of hyperbaric oxygen. J Oral Maxillofac Surg (2010) 1.45
Masseter tissue oxygen saturation predicts normal central venous oxygen saturation during early goal-directed therapy and predicts mortality in patients with severe sepsis. Crit Care Med (2012) 1.45
The absence of adrenal gland enlargement during septic shock predicts mortality: a computed tomography study of 239 patients. Anesthesiology (2011) 1.44
Neuropathological Correlates of Hyperglycemia During Prolonged Polymicrobial Sepsis in Mice. Shock (2015) 1.43
A randomized controlled trial of angiotensin-converting enzyme inhibition for skeletal muscle dysfunction in COPD. Chest (2014) 1.43
Steroid treatment in ARDS: a critical appraisal of the ARDS network trial and the recent literature. Intensive Care Med (2007) 1.36
Downregulation of the serum response factor/miR-1 axis in the quadriceps of patients with COPD. Thorax (2011) 1.35
Successful long-term treatment of hyponatremia in syndrome of inappropriate antidiuretic hormone secretion with satavaptan (SR121463B), an orally active nonpeptide vasopressin V2-receptor antagonist. Clin J Am Soc Nephrol (2006) 1.32
Activation and regulation of systemic inflammation in ARDS: rationale for prolonged glucocorticoid therapy. Chest (2009) 1.32
Long-term outcome of iatrogenic gas embolism. Intensive Care Med (2010) 1.28
Apoptosis of neurons in cardiovascular autonomic centres triggered by inducible nitric oxide synthase after death from septic shock. Lancet (2003) 1.28
Plasma exchange for Guillain-Barré syndrome. Cochrane Database Syst Rev (2012) 1.25
Dynamic data during hypotensive episode improves mortality predictions among patients with sepsis and hypotension. Crit Care Med (2013) 1.24
Lung function indices for predicting mortality in COPD. Eur Respir J (2013) 1.23
Vasopressin for treatment of vasodilatory shock: an ESICM systematic review and meta-analysis. Intensive Care Med (2011) 1.22
Glucocorticoids for ARDS: Just Do It! Chest (2007) 1.21
Bench-to-bedside review: Beta-adrenergic modulation in sepsis. Crit Care (2009) 1.18
Clinical practice guideline on diagnosis and treatment of hyponatraemia. Intensive Care Med (2014) 1.17
Whole-body muscle MRI in 20 patients suffering from late onset Pompe disease: Involvement patterns. Neuromuscul Disord (2011) 1.16
Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016. Crit Care Med (2017) 1.15
Clinical review: corticotherapy in sepsis. Crit Care (2003) 1.11
The COPD Assessment Test (CAT): short- and medium-term response to pulmonary rehabilitation. COPD (2012) 1.09
Cardiac and respiratory effects of continuous positive airway pressure and noninvasive ventilation in acute cardiac pulmonary edema. Crit Care Med (2002) 1.08
Effects of high doses of selenium, as sodium selenite, in septic shock: a placebo-controlled, randomized, double-blind, phase II study. Crit Care (2007) 1.08
Automatic air-leak compensation in neuromuscular patients: a feasibility study. Respir Med (2008) 1.07
Mortality of patients with heatstroke admitted to intensive care units during the 2003 heat wave in France: a national multiple-center risk-factor study. Crit Care Med (2006) 1.07
Understanding brain dysfunction in sepsis. Ann Intensive Care (2013) 1.06
Clinical predictive value of manual muscle strength testing during critical illness: an observational cohort study. Crit Care (2013) 1.05
Guillain-Barré syndrome and influenza virus infection. Clin Infect Dis (2009) 1.05
Cardiomyopathy in Duchenne muscular dystrophy: pathogenesis and therapeutics. Heart Fail Rev (2010) 1.05
Increased skeletal muscle-specific microRNA in the blood of patients with COPD. Thorax (2013) 1.05
Heterogeneity of quadriceps muscle phenotype in chronic obstructive pulmonary disease (Copd); implications for stratified medicine? Muscle Nerve (2013) 1.03
Neural respiratory drive as a physiological biomarker to monitor change during acute exacerbations of COPD. Thorax (2011) 1.03
The encephalopathy in sepsis. Crit Care Clin (2008) 1.03
Risk of death does not alter the efficacy of hydrocortisone therapy in a mouse E. coli pneumonia model: risk and corticosteroids in sepsis. Intensive Care Med (2007) 1.02
Glucocorticoid treatment in acute lung injury and acute respiratory distress syndrome. Crit Care Clin (2011) 1.01
Dissociation of serum dehydroepiandrosterone and dehydroepiandrosterone sulfate in septic shock. J Clin Endocrinol Metab (2006) 1.01
Effects of esmolol on systemic and pulmonary hemodynamics and on oxygenation in pigs with hypodynamic endotoxin shock. Intensive Care Med (2011) 0.99